Medicine & Life Sciences
eculizumab
100%
Atypical Hemolytic Uremic Syndrome
99%
Pregnancy
40%
Thrombotic Microangiopathies
36%
Posterior Leukoencephalopathy Syndrome
19%
Purpura
16%
Plasma Exchange
12%
Antiphospholipid Syndrome
11%
Haemolytic Anaemia
11%
Azathioprine
11%
Therapeutics
10%
Compassionate Use Trials
10%
Alternative Complement Pathway
9%
Hemolytic-Uremic Syndrome
8%
Disseminated Intravascular Coagulation
7%
Sjogren's Syndrome
7%
Mutation
7%
Methylprednisolone
7%
Prednisolone
6%
Pre-Eclampsia
6%
Proteinuria
6%
Acute Kidney Injury
6%
Complement Factor I
5%
Sepsis
5%
Kidney
5%
thiopurine methyltransferase
5%
streptolysin O
4%
Learning
4%
Monoclonal Antibodies
4%
Complement Inactivating Agents
4%
Complement C4
4%
Complement Factor H
4%
Thrombospondin 1
4%
Hydroxychloroquine
4%
Fetal Mortality
4%
Streptococcal Infections
4%
Disintegrins
4%
Antibodies, Monoclonal, Humanized
4%
Eclampsia
4%
Haptoglobins
4%
Complement C3
4%
Antirheumatic Agents
3%
Prothrombin
3%
Rheumatoid Factor
3%
Tracheostomy
3%
Maternal Mortality
3%
Liver Function Tests
3%
Prothrombin Time
3%
Confusion
3%
Interstitial Lung Diseases
3%
Rheumatology
3%
Hematology
3%
Metalloproteases
3%
Left Ventricular Dysfunction
3%
Hematuria
3%
Arthralgia
3%
Mechanical Ventilators
3%
Hemolysis
3%
Regulator Genes
3%
Genetic Testing
3%
First Pregnancy Trimester
3%
Streptococcus pneumoniae
3%
Methotrexate
3%
Uterus
3%
Autoantibodies
3%
White Matter
3%
Neuroimaging
3%
Obstetrics
2%
Critical Care
2%
Anti-Idiotypic Antibodies
2%
Immunosuppressive Agents
2%
Nervous System
2%
Pregnant Women
2%
Hospital Emergency Service
2%
Creatinine
2%
Reference Values
2%
Blood Platelets
2%
Seizures
2%
Patient Care
2%
Steroids
2%
Magnetic Resonance Imaging
2%
Mothers
2%
Biopsy
2%
Drug Therapy
1%
Recurrence
1%
DNA
1%
Survival
1%
Enzymes
1%
Liver
1%
Mortality
1%
Brain
1%
Incidence
1%
Infections
1%
Pharmaceutical Preparations
1%
Genes
1%
Population
1%